Skip to main content
Clinical Trials/IRCT2015073015968N3
IRCT2015073015968N3CompletedPhase 2

Effects of grape seed extract supplement on anthropometric measurements, serum lipids, inflammatory markers and neuropeptide Y in overweight or obese individuals

Vice chancellor for research, Shahid Beheshti university of medical sciences0 sites50 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20 years to 50 years (—)
Sex
All

Inclusion Criteria

  • Inclusion: Aged 20-50 years; Body mass index above 25 kg/m2
  • Exclusion criteria include: pregnancy, lactation; Menopause in women; History of liver disease; Kidney disease; Thyroid; Celiac; Diarrhea and Acute infection; Recent surgery; Weight loss diet in 6 months ago; Use of any drugs or supplements related to weight loss; Changes in body weight over three kilograms in 2 months ago; The use of Antioxidants supplementation in 3 months ago and Use of anticoagulants such as Aspirin,Warfarin.

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Vice chancellor for research, Shahid Beheshti university of medical sciences

Similar Trials

Effects of grape seed extract supplement... | Clinical Trial